US Patent Issued to Zealand Pharma on March 17 for "Pharmaceutical parenteral composition of dual GLP1/2 agonist" (Danish Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,025, issued on March 17, was assigned to Zealand Pharma A/S (Soborg, Denmark).

"Pharmaceutical parenteral composition of dual GLP1/2 agonist" was invented by Lise Giehm (Soborg, Denmark) and Alistair Vincent Gordon Edwards (Soborg, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions suitable for parenteral administration in human subjects. In particular, the present invention relates to isotonic pharmaceutical compositions for parenteral administration."

The patent was filed on June 12, 2020, under Application No. 17/617,670.

*For further information, including images, charts and tab...